Quality of Life analysis using ceramide cream for skin toxicity caused by cetuximab for advanced colorectal cancer (Multicentric study).
Phase 2
- Conditions
- colorectal cancer
- Registration Number
- JPRN-UMIN000009654
- Lead Sponsor
- Aizawa Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
1) Other reason causing skin symptom 2) Not apropriate to registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method